AMIODARONE (CORDARONE)

Question 1

CLASS

Answer 1

CLASS III ANTIDYSRHYTHMIC

Question 2

ACTIONS (2)

Answer 2

NONCOMPETITIVE ALPHA / BETA ADRENERGIC BLOCKING PROPERTIES

PROLONGS DURATION OF ACTION POTENTIAL AND EFFECTIVE REFRACTORY PERIOD WHICH SLOWS CONDUCTION

Question 3

INDICATIONS (4)

Answer 3

VF OR VT CARDIAC ARREST

CONTROL OF HEMODYNAMICALLY STABLE VT, POLYMORPHIC VT, AND WIDE COMPLEX TACHYCARDIA OF UNCERTAIN ORIGIN

REFRACTORY PSVTs, ATRIAL TACHYCARDIA, AND PHARMACOLOGICAL CARDIOVERSION OF AF

CONTROL RAPID VENTRICULAR RATE DUE TO ACCESSORY PATHWAY CONDUCTION IN PREEXCITED ATRIAL ARRHYTHMIAS

Question 4

DOSAGES / ROUTES (4)

Answer 4

VF / VT CARDIAC ARREST: 300 MG IV FOLLOWED BY 10 CC NS FLUSH

FOR PATIENTS NOT IN CARDIAC ARREST: 150 MG IV OVER 10 MINUTES FOLLOWED BY INFUSION OF 1 MG / MIN OVER 6 HOURS.

ONSET: WITHIN MINUTES

DURATION: VARIABLE

Question 5

STANDARD PREP

Answer 5

150 MG IN 3 CC AMPULE

Question 6

CONTRAINDICATIONS (4)

Answer 6

HYPERSENSITIVITY

CARDIOGENIC SHOCK

HYPOTENSION

PULMONARY CONGESTION

Question 7

SIDE EFFECTS

Answer 7

HYPOTENSION

BRADYCARDIA

HEPATOTOXICITY

CHF, PULMONARY FIBROSIS

MISC: FLUSHING, ABNORMAL SALIVATIONS

Question 8

PRECAUTIONS

Answer 8

DO NOT SHAKE VIAL BECAUSE IT WILL FOAM

MONITOR INFUSION RATE CAREFULLY

MONITOR VS, EKG, LUNG SOUNDS, AND MENTAL STATUS.